The weight-loss drug Zepbound was linked to a reduction in obstructive sleep apnea (OSA), according to new research. Pharmaceutical manufacturer Eli Lilly on Wednesday said injections of its obesity ...

(Tim Kitchen/Getty Images) Sleeping with a clunky breathing machine is a problem for many with sleep apnea, but a more comfortable alternative is on the horizon. In a recent clinical drug trial that ...

Millions of people in the U.S. have sleep apnea, most of whom aren’t getting treated for it. But a simple daily pill of an ...

People with obesity who received the weight-loss drug Zepbound had fewer obstructive sleep apnea events, or episodes of stopped breathing during sleep. The research by drug maker Eli Lilly included ...

The weekly injection is now the first drug treatment option cleared for patients with obesity and moderate-to-severe obstructive sleep apnea, or OSA, which refers to breathing interrupted during sleep ...

If sleep apnea is left untreated, one becomes vulnerable to many lifestyle ailments like diabetes and hypertension.

Adequate sleep (about seven to eight hours for adults) is crucial to your health, alertness and more. Obstructive sleep apnea ...

A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.

Continuous positive airway pressure (CPAP) is the standard treatment for treating obstructive sleep apnea (OSA), but clinicians should remember that weight loss is also an effective approach for ...

Chronic obstructive pulmonary disease (COPD) is known for causing breathing difficulties and limiting everyday activities.